Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

Abstract Background Even though chemotherapy-induced nausea and vomiting (CINV) can be well controlled in the acute phase, the incidence of delayed CINV remains high. In this study, we intend to investigate whether prolonged use of NK-1 receptor antagonist (RA) in addition to 5-HT3 RA and dexamethas...

Full description

Bibliographic Details
Main Authors: Ai Gao, Shasha Guan, Yinjuan Sun, Lingling Wang, Fanlu Meng, Xia Liu, Liyan Gu, Guo Li, Diansheng Zhong, Linlin Zhang
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Cancer
Subjects:
Prolonged
Fosaprepitant
Delayed CINV
HEC
Online Access:https://doi.org/10.1186/s12885-023-11070-3

Internet

https://doi.org/10.1186/s12885-023-11070-3

Similar Items